Loading...

Enhanced in Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis

IFNβ is a common therapeutic option to treat multiple sclerosis. It is unique among the family of type I IFNs in that it binds to the interferon receptors with high affinity, conferring exceptional biological properties. We have previously reported the generation of an interferon superagonist (dubbe...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Harari, Daniel, Kuhn, Nadine, Abramovich, Renne, Sasson, Keren, Zozulya, Alla L., Smith, Paul, Schlapschy, Martin, Aharoni, Rina, Köster, Mario, Eilam, Raya, Skerra, Arne, Schreiber, Gideon
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Biochemistry and Molecular Biology 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4200257/
https://ncbi.nlm.nih.gov/pubmed/25193661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M114.602474
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!